Paul Quinn, CWTE Limited
Date: 17 September 2026
Companion papers: Valuing Chelsea FC in 2026 (18 Aug 2026); Guggenheim and Chelsea FC (29 Aug 2026); Clearlake’s buy-out of Boehly & Walter (11 Sep 2026)
Summary
|
- The enterprise-value reading is now reported, not inferred. My 11 September paper concluded the £5bn was an enterprise figure. Bloomberg and the FT now both describe it that way.
- The consideration is c.£120m above my 11 September estimate (£950m vs c.£0.83bn). The price is consistent with £5bn less external debt only, with no deduction for net transfer payables, or with a true EV of c.£5.2–5.5bn.
- The price exceeds fundamentals by a wider margin than previously estimated. Implied equity of c.£3.70bn compares with a central c.£1.03bn and a trophy-buyer ceiling of £1.7–2.2bn.
- The co-founders’ personal participation is the most significant new fact. It signals conviction, but it also places the principals on both sides of a price that will inform the carrying value of fund-held capital.
- The sellers exit on a single-digit IRR. The ‘premium to initial investment’ language is technically accurate but economically thin. The return is at or below any reasonable cost of equity for junior, leveraged, illiquid sporting equity.
- Nothing in the club’s economics changes. The £794.2m senior maturity (13 July 2027), the compounding Ares PIK and the UEFA settlement now rest on a single, finite-life sponsor.
Transaction status and evidence grading
| Item | Position | Grade | Source |
|---|---|---|---|
| Clearlake affiliates to acquire Boehly’s and Walter’s interests | Signed; ‘will acquire’ | Confirmed | Chelsea FC statement, 16 Sep 2026 |
| Wyss remains a stakeholder | Not selling | Confirmed | Chelsea FC statement |
| Boehly leaves as Chairman | Leaves now per club; at completion per FT | Confirmed / Reported | Club; FT via PE Wire |
| Consideration c.£950m, cash | Combined for both stakes | Reported | FT (via PE Wire, ESPN, CNBC) |
| Enterprise value c.£5bn incl. debt | Headline valuation | Reported | Bloomberg; FT |
| Funding: Clearlake capital + co-founders; no new debt | Source of funds | Reported | FT (via PE Wire) |
| Completion by end-2026 | Timetable | Reported | FT (via PE Wire) |
| Clearlake exclusive purchase option over minority stakes | Pre-existing SHA term | Reported | Guardian, 11 Sep 2026 |
| Walter stake sold at a premium to initial investment | Seller characterisation | On-record (spokesperson) | Bloomberg / Guardian |
| Deferred / contingent consideration; conditions; lender consents; purchasing vehicle | — | Not disclosed | — |
| Wyss participation as a co-buyer | Ambiguous | Unresolved | PE Wire wording vs club statement |
Grades: Confirmed = primary document from a transaction party; Reported = named media citing people familiar; Analysis = author’s calculation or inference.
The confirmed record
The club’s statement of 16 September 2026 is the only primary document. It states that affiliates of Clearlake Capital Group, L.P. will acquire Todd Boehly’s ownership interest, that Clearlake will also acquire Mark Walter’s interest and thereby take full control, and that Hansjörg Wyss will remain a stakeholder and partner. It states that there will be no changes to day-to-day operations, leadership or strategy. It discloses no price, structure, financing, conditions or timetable.
Advisers
| Role | Adviser |
|---|---|
| Lead financial adviser on the transaction | Evercore (team led by Simon Robey) |
| Financial advisers to Clearlake | The Raine Group; BDT&MSD Partners; BofA Securities |
| Legal adviser to Clearlake and the Club | Sidley Austin LLP |
| Financial adviser to the sellers | Goldman Sachs & Co. LLC |
| Lead legal adviser to the sellers | Latham & Watkins LLP |
| Additional legal adviser to Mark Walter | Winston Taylor LLP (as named in the club statement) |
| Legal adviser to Hansjörg Wyss | Macfarlanes LLP |
Source: Chelsea FC, ‘Chelsea FC announces ownership transition’, 16 September 2026.
- Shared counsel for buyer and club. Sidley acts for the acquirer and the Club. Any reviewing regulator will ask how the interests of the club, and of the remaining minority, were protected where the controlling shareholder’s counsel also represents the company.
- Separate representation for Walter and for Wyss. Walter had counsel in addition to the sellers’ joint team, consistent with his distinct position under federal and SEC scrutiny. Wyss, who is not selling, also had his own counsel. That indicates his rights were negotiated: tag-along, the restructuring of the B-side limited partnership, and possibly participation as a buyer.
- Continuity with 2022. Raine ran the 2022 sale process; Robey Warshaw (now within Evercore) advised the 2022 acquirers. The same advisory network has priced both transactions.
Price and valuation
What is reported
The FT reports that Boehly and Walter will receive about £950m in cash for their combined interest, in a transaction valuing the club at around £5bn including debt. Bloomberg, citing people familiar, describes the £5bn as an enterprise value. ESPN reports each seller held 12.83%, Clearlake 61.5% and Wyss 12.83%. Companies House records 61.85% of 22 Holdco A Ordinary shares held by Blues Investment Midco LP, implying c.12.72% per B-side holder. The difference is a share-class and rounding convention and is immaterial to the conclusions.
What £950m implies (Analysis)
| Measure | £m | Comment |
|---|---|---|
| Consideration for 25.66% | 950 | FT, reported |
| Implied 100% equity (£950m ÷ 25.66%) | 3,702 | Deal-implied equity |
| Implied deductions from £5,000m EV | 1,298 | Net debt and other claims implied by the price |
| Senior facility (BlueCo 22), 30 June 2025 | 794 | Audited; matures 13 July 2027 |
| Ares PIK (22 Holdco), 30 June 2025 | 596 | Audited |
| Ares PIK accreted to 30 Sep 2026 (c.11.23%) | 681 | Author estimate |
| Net transfer payables (group) | c.300 | Author estimate; £208m audited for the standalone club |
| Equity at £5bn EV less senior + audited PIK | 3,610 | 25.66% = £926m |
| Equity at £5bn EV less senior + accreted PIK | 3,525 | 25.66% = £905m |
| Equity at £5bn EV less full stack (£1,775m) | 3,225 | 25.66% = £828m (11 Sep estimate) |
| EV implied by £3,702m equity + full stack | 5,477 | If all deductions apply |
Analysis. The £950m is therefore consistent with a £5bn EV net of external debt only, or with a true enterprise value of c.£5.2–5.5bn.
Reconciliation with prior Analysis Series work
| Measure | 11 Sep 2026 estimate | Now (on £950m) | Change |
|---|---|---|---|
| Basis of £5bn | Inferred enterprise | Reported enterprise | Inference confirmed |
| Consideration for both stakes | c.£828m | c.£950m | +c.£122m |
| Implied 100% equity | c.£3.2bn | c.£3.7bn | +c.£0.5bn |
| Multiple of central equity (c.£1.03bn) | c.3.1x | c.3.6x | Wider gap |
| Premium over trophy-buyer ceiling (£1.7–2.2bn) | c.£1.0–1.5bn | c.£1.5–2.0bn | Wider gap |
| Implied EV/revenue (FY25 group £536.5m) | 9.3x at £5.0bn | 9.3–10.2x at £5.0–5.5bn | Above every precedent |
|
Source of funds
What is reported
The only reported detail is that Clearlake will fund the purchase with its own capital and direct investments from co-founders Behdad Eghbali and José E. Feliciano, rather than taking on new debt for the purchase (FT, as reported by Private Equity Wire and European Business Magazine). It is single-sourced and unconfirmed by the parties.
Assessment (Analysis)
| Question | What is known | Assessment |
|---|---|---|
| Which Clearlake pool? | Not disclosed | Candidates: the original holding chain (Blues Investment Midco LP, Cayman); Fund VIII ($14.8bn, closed June 2026); a continuation or co-invest vehicle; firm balance sheet. Each carries different concentration and conflict implications. |
| Fund concentration | Clearlake equity c.£1,794m to June 2025 | Adding £950m takes exposure to c.£2.74bn before loss funding. Single-asset concentration limits (market practice 15–25% of commitments) make funding outside the original fund likely. |
| Co-founder personal capital | Reported | Signals conviction. Also places the principals on both sides of a price that will calibrate the carrying value of LP-owned capital. LPAC approval should have been sought. |
| ‘No new debt’ | Reported | Applies to acquisition debt only. Silent on the existing COP III-related Midco facility identified in the 6 May 2026 research, and on any later re-gearing. |
| Lender consents | Not disclosed | Change-of-control / permitted-holder definitions in the senior and Ares facilities are not public. Consent is routinely priced (fee, margin, security). Footprint: new or amended charges at 22 Holdco or BlueCo 22. |
| Cash to the club | None | Secondary transfer between shareholders. No effect on the balance sheet, income statement or cash of 22 Holdco, BlueCo 22 or the club. |
| On £950m, the implied value of Clearlake’s existing 61.5% is c.£2.28bn, against c.£0.63bn at my central equity. The transaction therefore supports c.£1.65bn of carrying value on capital Clearlake already holds, for a c.£0.69bn premium paid over central value on the stakes acquired: a ratio of roughly 2.4 to 1.
This describes incentives, not conduct. Private-market valuation guidelines treat a recent transaction as a calibration input only where it is orderly and representative. A single-buyer transaction under an exclusive option, with the principals investing personally, should not be treated as such. |
Settlement terms
| Term | Status | Grade |
|---|---|---|
| Form of consideration | Cash | Reported (FT) |
| Deferred, contingent or earn-out elements | None reported; absence not confirmed | Not disclosed |
| Completion | Expected by end-2026 | Reported (FT) |
| Split between Boehly and Walter | Not disclosed; equal stakes imply c.£475m each | Analysis |
| Chairmanship | Club: Boehly ‘now leaves’; FT: steps down at completion | Conflicting |
| Conditions (Premier League OADT, IFR, lender consents) | Not disclosed | Not disclosed |
| Purchasing entity | ‘Affiliates of Clearlake Capital Group, L.P.’ | Confirmed (generic) |
| Transfer mechanics | B-side held via Blueco 22 Holdings L.P. (LP022606; Boehly sole GP). Either LP interests transfer or B shares are carved out; a replacement GP is required as Wyss remains | Analysis |
| Wyss position | Remains; PE Wire says Clearlake acquires ‘alongside’ Wyss, which may indicate co-buying | Unresolved |
| Pre-existing constraint | No sale to third parties without first offering Clearlake an exclusive option | Reported (Guardian) |
| Pre-agreed chair handover | Clearlake nominee was due to replace Boehly in 2027 | Reported (Guardian; Goal) |
| Immediate or otherwise?
The reporting describes cash consideration, and no source mentions deferral, earn-out or instruments. The absence of any structural element has not, however, been confirmed by the parties. If any part is deferred or contingent (for example on a stadium consent, the July 2027 refinancing or an onward sale), the present value to the sellers is below £950m and the returns estimated below are overstated. |
The sellers’ position and narrative
A spokesperson for Walter stated that the transaction values his stake at a premium to his initial investment, that Walter did not initiate it, that it had been in the works for some time, and that he intends to make further sports investments. The Guardian reports that talks intensified in August as Walter sought to raise funds to pay off insurers following a US federal investigation. Bloomberg’s original reporting describes the probe as concerning the disclosure of related-party private credit holdings by insurers Walter controls. That is the better-sourced characterisation. No charges have been brought against Walter.
Both accounts can be true. Clearlake has been linked with buying out Boehly for two years, and Walter’s liquidity need turned a slow-burning discussion into a live one. The valuation significance is that one seller was a known, motivated seller dealing with the only buyer permitted to buy. In an open market that combination produces a discount. That a premium was paid is diagnostic of buyer-specific motives: control, removal of probe contagion before the 2027 refinancing, sole stadium decision rights, and carrying-value support.
The phrase ‘premium to initial investment’ also needs care. If ‘initial investment’ means acquisition equity only (c.£312m per holder on this model), the premium is c.£163m. Measured against all capital contributed (c.£369m or more), it is c.£106m or less.
Return model: Boehly and Walter
Methodology and assumptions
| Input | Assumption | Basis / grade |
|---|---|---|
| Cumulative 22 Holdco equity to 30 Jun 2025 | £2,900m | 22 Holdco FY25 accounts (Confirmed, rounded) |
| Per-holder share of B-side | 12.717% (38.15% ÷ 3) | Companies House A-share 61.85%; equal B-side thirds (Analysis) |
| Acquisition equity, 30 May 2022 | £2,450m | £2.9bn less £450m FY25 round; assumes nil equity in FY23–FY24 (Analysis) |
| October 2024 round, 13 Oct 2024 | £190m; B-side 6.5m of 19m shares (34.2%) | Companies House filing as reported (Confirmed / Reported) |
| Balance of FY25 round | £260m, pro-rata, dated mid-Jan 2025 | Nov 2024 – Mar 2025 allotments (Analysis) |
| FY2025/26 equity calls | £0 / £250m / £500m (group), dated 31 Dec 2025 | Unknown until FY26 accounts (Scenario) |
| Proceeds per holder | £475.0m / £463.1m / £452.3m | £950m ÷ 2; and the £926m and £905m readings in Section 4.2 (Scenario) |
| Completion date | 31 Dec 2026 (base); 31 Mar 2027 (slip) | FT: by end-2026 (Reported) |
| FX (USD view) | 1.26 / 1.305 / 1.22 / 1.34; exit 1.337 | Approximate market rates; exit from CNBC conversion (Analysis) |
| Exclusions | Fees, tax, carry, side letters, non-cash benefits | Not disclosed |
Cost basis per holder
| Date | Tranche | Group equity (£m) | B-side share | Per holder (£m) |
|---|---|---|---|---|
| 30 May 2022 | Acquisition equity | 2,450 | 38.15% | 311.6 |
| 13 Oct 2024 | FY25 round, tranche 1 | 190 | 34.21% | 21.7 |
| 15 Jan 2025 (midpoint) | FY25 round, balance | 260 | c.41.0% (balancing) | 35.6 |
| To 30 Jun 2025 | Cumulative | 2,900 | 38.15% | 368.8 |
| 31 Dec 2025 | FY26 calls (scenario) | 0 / 250 / 500 | 38.15% | 0 / 31.8 / 63.6 |
Analysis. Prior pro-rata basis (12.8% × £2.9bn = £371m) is within £3m of this figure.
Base-case cash-flow schedule (per holder, £m)
| Date | Cash flow | Nature | Cumulative |
|---|---|---|---|
| 30 May 2022 | (311.6) | Acquisition equity | (311.6) |
| 13 Oct 2024 | (21.7) | Equity call | (333.3) |
| 15 Jan 2025 | (35.6) | Equity call | (368.8) |
| 31 Dec 2026 | 475.0 | Sale proceeds (cash) | 106.2 |
Base case: FY26 calls nil; proceeds £475m; completion 31 December 2026. MOIC 1.29x; IRR 6.2%; holding period c.4.6 years.
Results by scenario (completion 31 Dec 2026)
| Proceeds per holder | FY26 group calls | Invested | Gain | MOIC | IRR (GBP) |
|---|---|---|---|---|---|
| £475.0m | £0m | £368.8m | £106.2m | 1.29x | 6.2% |
| £475.0m | £250m | £400.6m | £74.4m | 1.19x | 4.4% |
| £475.0m | £500m | £432.4m | £42.6m | 1.10x | 2.5% |
| £463.1m | £0m | £368.8m | £94.3m | 1.26x | 5.5% |
| £463.1m | £250m | £400.6m | £62.5m | 1.16x | 3.7% |
| £463.1m | £500m | £432.4m | £30.7m | 1.07x | 1.9% |
| £452.3m | £0m | £368.8m | £83.5m | 1.23x | 5.0% |
| £452.3m | £250m | £400.6m | £51.7m | 1.13x | 3.1% |
| £452.3m | £500m | £432.4m | £19.9m | 1.05x | 1.2% |
Completion slip sensitivity (IRR, GBP)
| Proceeds / FY26 calls | £0m | £250m | £500m |
|---|---|---|---|
| £475.0m, completes 31 Dec 2026 | 6.2% | 4.4% | 2.5% |
| £475.0m, completes 31 Mar 2027 | 5.8% | 4.1% | 2.4% |
| £463.1m, completes 31 Dec 2026 | 5.5% | 3.7% | 1.9% |
| £463.1m, completes 31 Mar 2027 | 5.2% | 3.5% | 1.7% |
| £452.3m, completes 31 Dec 2026 | 5.0% | 3.1% | 1.2% |
| £452.3m, completes 31 Mar 2027 | 4.7% | 2.9% | 1.1% |
Performance against hurdle rates (proceeds £475m, 31 Dec 2026)
Each contribution is compounded to completion at the hurdle rate. The excess (shortfall) is the proceeds less that compounded value.
| FY26 group calls | Hurdle 4% (c.gilts) | Excess | Hurdle 8% | Excess | Hurdle 12% | Excess |
|---|---|---|---|---|---|---|
| £0m | £435.0m | £40.0m | £510.5m | (£35.5m) | £596.3m | (£121.3m) |
| £250m | £468.1m | £6.9m | £544.9m | (£69.9m) | £631.9m | (£156.9m) |
| £500m | £501.1m | (£26.1m) | £579.2m | (£104.2m) | £667.5m | (£192.5m) |
Analysis. 4% approximates the average sterling risk-free rate over the period; 8% and 12% bracket a plausible cost of equity for junior, leveraged, illiquid sporting equity.
US dollar view
| FY26 group calls | Invested (US$m) | Proceeds (US$m) | MOIC | IRR (USD) |
|---|---|---|---|---|
| £0m | 464.2 | 635.1 | 1.37x | 7.7% |
| £250m | 506.8 | 635.1 | 1.25x | 5.8% |
| £500m | 549.4 | 635.1 | 1.16x | 3.9% |
Analysis. Sterling’s recovery from c.1.22 (January 2025) and c.1.26 (May 2022) to c.1.34 adds c.1.4–1.5 percentage points for a dollar-based investor. FX rates are approximations.
Combined position of the two sellers (base case)
| Measure | Boehly | Walter | Combined |
|---|---|---|---|
| Capital contributed to 30 Jun 2025 | £368.8m | £368.8m | £737.7m |
| Proceeds | £475.0m | £475.0m | £950.0m |
| Nominal gain | £106.2m | £106.2m | £212.3m |
| MOIC / IRR (GBP) | 1.29x / 6.2% | 1.29x / 6.2% | 1.29x / 6.2% |
| Excess over 4% hurdle | £40.0m | £40.0m | £80.0m |
| Excess over 8% hurdle | (£35.5m) | (£35.5m) | (£71.0m) |
|
| Model limitations
Pre-FY25 equity timing is inferred from the £2.9bn cumulative figure; any FY23–FY24 contributions would shift cost later and raise the IRR marginally. FY26 calls are the largest unknown and are not visible until the 22 Holdco FY2025/26 accounts (due 31 March 2027). B-side contributions are allocated equally between the three B-side holders; the look-through split within Blueco 22 Holdings L.P. is not filed. The equal split of £950m between Boehly and Walter is an assumption. The model excludes transaction fees, tax, carried interest, any side-letter economics, deferred or contingent consideration, and non-financial benefits of the chairmanship. |
Clearlake’s position after completion (Analysis)
| Measure | Wyss holds; Clearlake buys all | Wyss co-buys pro rata |
|---|---|---|
| Clearlake cash paid | £950m | c.£786m |
| Wyss cash paid | — | c.£164m |
| Clearlake equity to June 2025 + purchase | c.£2,744m | c.£2,580m |
| Clearlake holding | c.87.2% | c.82.7% |
| Wyss holding | c.12.8% | c.17.3% |
| Share of future loss funding (pro rata) | c.87% | c.83% |
| Implied value of holding at deal equity (£3.70bn) | c.£3.23bn (1.18x cost) | c.£3.06bn (1.19x cost) |
| Implied value at central equity (c.£1.03bn) | c.£0.90bn (0.33x cost) | c.£0.85bn (0.33x cost) |
Analysis. Excludes FY26 equity calls and any back-leverage. ‘Full control’ does not mean 100% ownership while Wyss remains.
Owner funding narrows from four sources (a private equity sponsor and three individual billionaires without fund-life constraints) to one finite-life sponsor, plus a residual minority. The £794.2m senior maturity on 13 July 2027, the compounding Ares PIK (c.£740m by that date on my estimate) and the UEFA settlement obligations now depend on that sponsor’s fundraising and exit cycle. The governance deadlock is resolved; the funding risk is concentrated.
Implications
For regulators (IFR, Premier League, UEFA)
- Treat the £950m / £5bn as a related-party, single-buyer price with no evidential weight on market value, consistent with UEFA’s treatment of the 2024 women’s team sale.
- Require disclosure of the purchasing vehicle, the split between fund capital and the co-founders’ personal capital, and any debt at Midco or fund level.
- Test committed funding through the July 2027 maturity and the remaining UEFA settlement period at consolidated parent level.
For lenders (senior syndicate and Ares)
- Do not import the headline into loan-to-value analysis; the realistic equity cushion remains c.£1.0bn.
- Price sponsor concentration explicitly in any consent or refinancing, and seek formal support undertakings.
For the Chelsea board
- Disclose the transaction, its funding and any consents as a post-balance-sheet event in the FY2025/26 accounts, with full related-party detail.
- Convert the governance dividend into a mandated refinancing plan, a stadium proposal capable of Chelsea Pitch Owners consent, and a cost reset consistent with the 70% squad cost ratio.
For the remaining minority
- Wyss is now a lone minority under the same exclusive-option architecture. His separate counsel suggests negotiated protections; their terms should be disclosed to the regulator.
Questions to put to the parties
- What equity value per share does the £950m imply, and does it reflect the Class A preference and any Ares warrants?
- Is any part of the consideration deferred, contingent or payable in instruments?
- Which vehicle is the purchaser, and how much comes from Clearlake funds, continuation or co-invest vehicles, and the co-founders personally?
- Did the fund’s LP advisory committee approve the co-founders’ personal participation and the price?
- Do the senior or Ares facilities require consent, and on what terms was it given?
- Is Hansjörg Wyss participating as a buyer, and what rights does he retain?
- Will the price be used to value Clearlake’s existing holding, and was an independent valuation or fairness opinion obtained?
- What committed funding does Clearlake provide through July 2027 and the UEFA settlement period?
Signals to monitor
| Signal | Where | Why it matters |
|---|---|---|
| PSC changes at 22 Holdco; GP change at Blueco 22 Holdings L.P. | Companies House | Evidence of completion and the post-deal control chain |
| B-to-A class conversions, transfers or new allotments | Companies House (confirmation statement, SH01, SH08) | Transfer mechanics; any primary capital alongside |
| New or amended charges at 22 Holdco / BlueCo 22 | Companies House charge register | Consent pricing, enhanced security, back-leverage |
| Premier League / IFR approval | PL / IFR | Source-of-funds scrutiny |
| Wyss clarification | Club / press / Companies House | 87.2% vs c.82.7% outcome |
| Ares September marks on the 22 Holdco loan | SEC filings (November 2026) | Lender view against the £5bn narrative |
| Senior refinancing mandate | Press / charge register | The critical near-term test |
| 22 Holdco FY2025/26 accounts | Companies House, due 31 Mar 2027 | FY26 equity calls (return model input); post-balance-sheet disclosure |
Caveats and data limitations
| Data limitations
The only primary document is the club statement, which discloses no terms. The £950m, the £5bn enterprise value, the cash form, the funding sources and the timetable are all reported by named media citing people familiar, principally the FT, and are unconfirmed by the parties. The latest audited accounts are for the year ended 30 June 2025. FY2025/26 equity calls, trading and the summer 2026 window are not yet in filed accounts. The cost basis relies on the rounded £2.9bn cumulative equity figure and on inferred timing. The Ares PIK accretion and group net transfer payables are author estimates. The equity/enterprise basis is as reported and has not been confirmed by the parties. Liquidation-preference mechanics and Ares warrant terms are not fully public. FX rates are approximations. Hurdle rates are illustrative. Fund-mark arithmetic describes incentives, not conduct. No allegation is made against any party. No charges have been brought against Mark Walter. |
Principal sources
- Chelsea FC, ‘Chelsea FC announces ownership transition’, 16 September 2026 (primary).
- Financial Times, report on £950m consideration and £5bn valuation, 16–17 September 2026, as relayed by Private Equity Wire, ESPN, CNBC, AFP/France 24 and European Business Magazine.
- Bloomberg, ‘Boehly, Walter Sell Chelsea Stakes to Clearlake After Feud’, 16 September 2026; ‘Walter, Boehly Near Sale of Chelsea FC Stakes to Clearlake’, 10 September 2026.
- The Guardian, ‘Clearlake Capital close on buying out Chelsea co-owners Todd Boehly and Mark Walter’, 10–11 September 2026 (syndicated).
- ESPN, CNBC, AP and Inside World Football reporting, September 2026; Sky Sports, August 2026.
- Companies House: 22 Holdco Limited and BlueCo 22 Limited consolidated accounts, year ended 30 June 2025 (filed 12 April 2026); SH01 filings (October 2024 – March 2025); PSC and charge registers; Blueco 22 Holdings L.P. (LP022606).
- Greg Cordell, Ownership Diagrams 2024/25 Premier League Clubs (May 2025) and filings commentary (October 2024).
- Chelsea FC 2022 sale statements and Business Wire completion release, May 2022.
- The Analysis Series (theesk.org): 15 April, 2 May, 6 May, 23 July, 19 August, 29 August and 11 September 2026.